Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1)

Karlyn A. Martin; Nicola Lancki; Celina Li; M. Elaine Eyster; Kristen Sanfilippo; Isabela A. Woller; Scott C. Woller; Lisa Baumann Kreuziger; Rachel P. Rosovsky

doi:10.1007/s11239-023-02803-z

Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1)

Karlyn A. Martin
, Nicola Lancki
, Celina Li
, M. Elaine Eyster
, Kristen Sanfilippo
, Isabela A. Woller
, Scott C. Woller
, Lisa Baumann Kreuziger
, Rachel P. Rosovsky

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Journal of Thrombosis and Thrombolysis In the abstract of the original version of the article, the odds ratio for the 12-month recurrent VTE rate was incorrect and has been corrected in this version. In the original version of the article, the odds ratio was correctly reported in the results section of the main manuscript.

Original language	English (US)
Pages (from-to)	775
Number of pages	1
Journal	Journal of Thrombosis and Thrombolysis
Volume	55
Issue number	4
DOIs	https://doi.org/10.1007/s11239-023-02803-z
State	Published - May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Hematology
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s11239-023-02803-z

Fingerprint

Dive into the research topics of 'Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1)'. Together they form a unique fingerprint.

Cite this

Martin, K. A., Lancki, N., Li, C., Eyster, M. E., Sanfilippo, K., Woller, I. A., Woller, S. C., Kreuziger, L. B., & Rosovsky, R. P. (2023). Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1). Journal of Thrombosis and Thrombolysis, 55(4), 775. https://doi.org/10.1007/s11239-023-02803-z

Martin, Karlyn A. ; Lancki, Nicola ; Li, Celina et al. / Correction to : DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1). In: Journal of Thrombosis and Thrombolysis. 2023 ; Vol. 55, No. 4. pp. 775.

@article{d5a93bfb7bd240e696871131bf33ebb2,

title = "Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1)",

abstract = "Journal of Thrombosis and Thrombolysis In the abstract of the original version of the article, the odds ratio for the 12-month recurrent VTE rate was incorrect and has been corrected in this version. In the original version of the article, the odds ratio was correctly reported in the results section of the main manuscript.",

author = "Martin, \{Karlyn A.\} and Nicola Lancki and Celina Li and Eyster, \{M. Elaine\} and Kristen Sanfilippo and Woller, \{Isabela A.\} and Woller, \{Scott C.\} and Kreuziger, \{Lisa Baumann\} and Rosovsky, \{Rachel P.\}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2023",

month = may,

doi = "10.1007/s11239-023-02803-z",

language = "English (US)",

volume = "55",

pages = "775",

journal = "Journal of Thrombosis and Thrombolysis",

issn = "0929-5305",

publisher = "Springer",

number = "4",

}

Martin, KA, Lancki, N, Li, C, Eyster, ME, Sanfilippo, K, Woller, IA, Woller, SC, Kreuziger, LB & Rosovsky, RP 2023, 'Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1)', Journal of Thrombosis and Thrombolysis, vol. 55, no. 4, pp. 775. https://doi.org/10.1007/s11239-023-02803-z

Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1). / Martin, Karlyn A.; Lancki, Nicola; Li, Celina et al.
In: Journal of Thrombosis and Thrombolysis, Vol. 55, No. 4, 05.2023, p. 775.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction to

T2 - DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1)

AU - Martin, Karlyn A.

AU - Lancki, Nicola

AU - Li, Celina

AU - Eyster, M. Elaine

AU - Sanfilippo, Kristen

AU - Woller, Isabela A.

AU - Woller, Scott C.

AU - Kreuziger, Lisa Baumann

AU - Rosovsky, Rachel P.

PY - 2023/5

Y1 - 2023/5

N2 - Journal of Thrombosis and Thrombolysis In the abstract of the original version of the article, the odds ratio for the 12-month recurrent VTE rate was incorrect and has been corrected in this version. In the original version of the article, the odds ratio was correctly reported in the results section of the main manuscript.

AB - Journal of Thrombosis and Thrombolysis In the abstract of the original version of the article, the odds ratio for the 12-month recurrent VTE rate was incorrect and has been corrected in this version. In the original version of the article, the odds ratio was correctly reported in the results section of the main manuscript.

UR - https://www.scopus.com/pages/publications/85151321366

UR - https://www.scopus.com/pages/publications/85151321366#tab=citedBy

U2 - 10.1007/s11239-023-02803-z

DO - 10.1007/s11239-023-02803-z

M3 - Comment/debate

C2 - 36995647

AN - SCOPUS:85151321366

SN - 0929-5305

VL - 55

SP - 775

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

IS - 4

ER -

Martin KA, Lancki N, Li C, Eyster ME, Sanfilippo K, Woller IA et al. Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1). Journal of Thrombosis and Thrombolysis. 2023 May;55(4):775. doi: 10.1007/s11239-023-02803-z

Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network (Journal of Thrombosis and Thrombolysis, (2023), 55, 4, (685-690), 10.1007/s11239-023-02774-1)

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this